dipyridamole has been researched along with Rheumatism in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For patients who are in atrial fibrillation, have permanent pacemakers, who cannot augment their heart rate to a minimum of 85% MPHR, dipyridamole thallium is an acceptable alternative." | 4.80 | Detection and management of coronary artery disease in patients with rheumatologic disorders. ( Ghaffari, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghaffari, S | 1 |
1 review available for dipyridamole and Rheumatism
| Article | Year |
|---|---|
Detection and management of coronary artery disease in patients with rheumatologic disorders.
Topics: Atrial Fibrillation; Cardiac Catheterization; Coronary Disease; Dipyridamole; Dobutamine; Echocardio | 1999 |